(Q51589461)

7 April 2018

title

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology. (English)

1 reference

7 April 2018

1 reference

cervix uterine cancer

1 reference

Jaume Ordi

9

0 references

author name string

K Ulrich Petry

1

1 reference

7 April 2018

Dietmar Schmidt

2

1 reference

7 April 2018

Sarah Scherbring

3

1 reference

7 April 2018

Alexander Luyten

4

1 reference

7 April 2018

Axel Reinecke-Lüthge

5

1 reference

7 April 2018

Christine Bergeron

6

1 reference

7 April 2018

Friedrich Kommoss

7

1 reference

7 April 2018

Thomas Löning

8

1 reference

7 April 2018

Sigrid Regauer

10

1 reference

7 April 2018

Ruediger Ridder

11

1 reference

7 April 2018

language of work or name

English

0 references

publication date

21 March 2011

1 reference

7 April 2018

published in

Gynecologic Oncology

1 reference

7 April 2018

volume

121

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

505-509

1 reference

7 April 2018

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Trials comparing cytology with human papillomavirus screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Screening: HPV testing for cervical cancer: the good, the bad, and the ugly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

The 2001 Bethesda System: terminology for reporting results of cervical cytology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

The sensitivity and specificity of p16(INK4a) cytology vs HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL pap cytology results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

Toward objective cervical cancer screening: maybe the eyes do have it

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.02.033

10.1016/J.YGYNO.2011.02.033

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

21420158

1 reference

7 April 2018